These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25091789)

  • 21. The Association Between the Decision to Withdraw Life-Sustaining Therapy and Patient Mortality in U.K. ICUs.
    Maharaj R; Harrison DA; Rowan K
    Crit Care Med; 2022 Apr; 50(4):576-585. PubMed ID: 34402458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a Devastating Brain Injury Pathway on Outcomes, Resources, and Organ Donation: 3 Years' Experience in a Regional Neurosciences ICU.
    Rivers J; Manara AR; Thomas I; Derrick E
    Neurocrit Care; 2020 Aug; 33(1):165-172. PubMed ID: 31773544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global variability in withholding and withdrawal of life-sustaining treatment in the intensive care unit: a systematic review.
    Mark NM; Rayner SG; Lee NJ; Curtis JR
    Intensive Care Med; 2015 Sep; 41(9):1572-85. PubMed ID: 25904183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. End-of-life practices in patients with devastating brain injury in Spain: implications for organ donation.
    Domínguez-Gil B; Coll E; Pont T; Lebrón M; Miñambres E; Coronil A; Quindós B; Herrero JE; Liébanas C; Marcelo B; Sanmartín AM; Matesanz R;
    Med Intensiva; 2017 Apr; 41(3):162-173. PubMed ID: 27789022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Withholding and withdrawal of life-sustaining treatments in intensive care units in Asia.
    Phua J; Joynt GM; Nishimura M; Deng Y; Myatra SN; Chan YH; Binh NG; Tan CC; Faruq MO; Arabi YM; Wahjuprajitno B; Liu SF; Hashemian SM; Kashif W; Staworn D; Palo JE; Koh Y;
    JAMA Intern Med; 2015 Mar; 175(3):363-71. PubMed ID: 25581712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled donation after circulatory death in post-cardiac arrest patients: Estimates from a large registry.
    Renaudier M; Binois Y; Dumas F; Lamhaut L; Beganton F; Jost D; Charpentier J; Lesieur O; Marijon E; Jouven X; Cariou A; Bougouin W;
    Resuscitation; 2024 Jun; 199():110202. PubMed ID: 38582445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How France launched its donation after cardiac death program.
    Antoine C; Mourey F; Prada-Bordenave E;
    Ann Fr Anesth Reanim; 2014 Feb; 33(2):138-43. PubMed ID: 24388490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit.
    Guidet B; Flaatten H; Boumendil A; Morandi A; Andersen FH; Artigas A; Bertolini G; Cecconi M; Christensen S; Faraldi L; Fjølner J; Jung C; Marsh B; Moreno R; Oeyen S; Öhman CA; Pinto BB; Soliman IW; Szczeklik W; Valentin A; Watson X; Zafeiridis T; De Lange DW;
    Intensive Care Med; 2018 Jul; 44(7):1027-1038. PubMed ID: 29774388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of the ethics committee of the French Intensive Care Society to describing a scenario for implementing organ donation after Maastricht type III cardiocirculatory death in France.
    Graftieaux JP; Bollaert PE; Haddad L; Kentish-Barnes N; Nitenberg G; Robert R; Villers D; Dreyfuss D
    Ann Intensive Care; 2012 Jul; 2(1):23. PubMed ID: 22747673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Death in an intensive care unit. Influence of life support withholding and withdrawal].
    Gherardi C; Chaves M; Capdevila A; Tavella M; Sarquis S; Irrazabal C
    Medicina (B Aires); 2006; 66(3):237-41. PubMed ID: 16871911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of donor time to cardiac arrest in lung donation after circulatory death.
    Qaqish R; Watanabe Y; Hoetzenecker K; Yeung J; Chen M; Pierre A; Yasufuku K; Donahoe L; de Perrot M; Waddell T; Keshavjee S; Cypel M
    J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1546-1555.e1. PubMed ID: 32747131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The practice of and documentation on withholding and withdrawing life support: a retrospective study in two Dutch intensive care units.
    Spronk PE; Kuiper AV; Rommes JH; Korevaar JC; Schultz MJ
    Anesth Analg; 2009 Sep; 109(3):841-6. PubMed ID: 19690256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of time of death after withdrawal of life-sustaining treatment in potential donors after cardiac death*.
    Wind J; Snoeijs MG; Brugman CA; Vervelde J; Zwaveling J; van Mook WN; van Heurn EL
    Crit Care Med; 2012 Mar; 40(3):766-9. PubMed ID: 21983365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective review of a large cohort of patients undergoing the process of withholding or withdrawal of life support.
    Keenan SP; Busche KD; Chen LM; McCarthy L; Inman KJ; Sibbald WJ
    Crit Care Med; 1997 Aug; 25(8):1324-31. PubMed ID: 9267945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting time to asystole following withdrawal of life-sustaining treatment: a systematic review.
    Nicolson C; Burke A; Gardiner D; Harvey D; Munshi L; Shaw M; Tsanas A; Lone N; Puxty K
    Anaesthesia; 2024 Jun; 79(6):638-649. PubMed ID: 38301032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. End-of-life care in the intensive care unit: the Irish Ethicus data.
    Collins N; Phelan D; Marsh B; Sprung CL
    Crit Care Resusc; 2006 Dec; 8(4):315-20. PubMed ID: 17227268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in limitations of life-sustaining treatments over time in a French intensive care unit: A prospective observational study.
    Lesieur O; Herbland A; Cabasson S; Hoppe MA; Guillaume F; Leloup M
    J Crit Care; 2018 Oct; 47():21-29. PubMed ID: 29886063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decisions to withhold or withdraw life-sustaining treatment in a Norwegian intensive care unit.
    Hoel H; Skjaker SA; Haagensen R; Stavem K
    Acta Anaesthesiol Scand; 2014 Mar; 58(3):329-36. PubMed ID: 24405518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study.
    Avidan A; Sprung CL; Schefold JC; Ricou B; Hartog CS; Nates JL; Jaschinski U; Lobo SM; Joynt GM; Lesieur O; Weiss M; Antonelli M; Bülow HH; Bocci MG; Robertsen A; Anstey MH; Estébanez-Montiel B; Lautrette A; Gruber A; Estella A; Mullick S; Sreedharan R; Michalsen A; Feldman C; Tisljar K; Posch M; Ovu S; Tamowicz B; Demoule A; DeKeyser Ganz F; Pargger H; Noto A; Metnitz P; Zubek L; de la Guardia V; Danbury CM; Szűcs O; Protti A; Filipe M; Simpson SQ; Green C; Giannini AM; Soliman IW; Piras C; Caser EB; Hache-Marliere M; Mentzelopoulos SD;
    Lancet Respir Med; 2021 Oct; 9(10):1101-1110. PubMed ID: 34364537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. French intensivists do not apply American recommendations regarding decisions to forgo life-sustaining therapy.
    Pochard F; Azoulay E; Chevret S; Vinsonneau C; Grassin M; Lemaire F; Hervé C; Schlemmer B; Zittoun R; Dhainaut JF;
    Crit Care Med; 2001 Oct; 29(10):1887-92. PubMed ID: 11588446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.